Alliancebernstein L.P. Sorrento Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$1.51 - $2.88 $61,457 - $117,216	-40,700 Reduced 12.71%	279,400 $439,000
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $1,800 - $4,410	900 Added 0.28%	320,100 $746,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $465,000 - $723,000	-100,000 Reduced 23.85%	319,200 $1.48 Million
Q3 2021 Nov 10, 2021	BUY	$7.41 - $10.99 $692,094 - $1.03 Million	93,400 Added 28.67%	419,200 $3.2 Million
Q1 2021 May 06, 2021	BUY	$7.03 - $16.51 $63,973 - $150,241	9,100 Added 2.87%	325,800 $2.69 Million
Q4 2020 Feb 08, 2021	BUY	$5.76 - $11.95 $13,248 - $27,485	2,300 Added 0.73%	316,700 $2.16 Million
Q3 2020 Nov 12, 2020	BUY	$6.17 - $18.82 $344,903 - $1.05 Million	55,900 Added 21.62%	314,400 $3.51 Million
Q2 2020 Aug 13, 2020	SELL	$1.73 - $6.76 $717,777 - $2.8 Million	-414,900 Reduced 61.61%	258,500 $1.62 Million
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $628,000 - $1.9 Million	400,000 Added 146.31%	673,400 $1.24 Million
Q4 2019 Feb 18, 2020	BUY	$1.45 - $4.17 $145,000 - $417,000	100,000 Added 57.67%	273,400 $924,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $36,285 - $47,613	17,700 Added 11.37%	173,400 $371,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $25,899 - $42,486	9,700 Added 6.64%	155,700 $416,000
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $47,616 - $152,064	25,600 Added 21.26%	146,000 $694,000
Q4 2018 Feb 13, 2019	BUY	$2.01 - $4.24 $72,962 - $153,912	36,300 Added 43.16%	120,400 $289,000
Q3 2018 Nov 08, 2018	BUY	$4.22 - $7.5 $156,984 - $279,000	37,200 Added 79.32%	84,100 $370,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $222,775 - $375,200	46,900 New	46,900 $338,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account